- Home
- Services
- usa new jersey
- immune systems
Show results for
Refine by
Immune Systems Services In Usa New Jersey
6 services found
Manufactured by:Synbio Technologies LLC based in, NEW JERSEY (USA)
The immune system is a very robust “antibody factory” that consistently produces antibodies to fight infections and diseases by recognizing and targeting infected cells or pathogens (antigens). The emergence of single B cell antibody technology has enabled a new strategy for discovery of naturally occurring antibody drugs. ...
Manufactured by:Synbio Technologies LLC based in, NEW JERSEY (USA)
Immune Repertoire refers to the set of all functionally diversified B cells and T cells in the circulatory system of an individual at any given time. Immune repertoire sequencing (Immuno-Seq) targets at T/B lymphocytes and utilizes the 5’ Rapid Amplification of cDNA Ends (RACE) Technology. ...
by:American Water based inCamden, NEW JERSEY (USA)
Healthcare facilities pose a special situation for managing Legionella risk due to the increased number of people who may be susceptible to infection, such as the elderly, and those with weak immune systems, as well as the complexity of their plumbing, heating and cooling systems. For this reason, it is important for health care facility managers ...
Manufactured by:CytoSorbents Corporation based inMonmouth Junction, NEW JERSEY (USA)
Experiences showed that the use of CytoSorb can help the body to fight the harmful effects of COVID-19, if one or more of the following criteria is ...
Manufactured by:Synbio Technologies LLC based in, NEW JERSEY (USA)
Accurately acquiring antibody sequences is one of the most important prerequisites to achieving antibody functional optimization and expression of recombinant engineering antibodies. Antibody sequencing and analysis also plays a key role for researchers publishing articles and apply for patents. The data is even more critical for pharmaceutical enterprises to further their research and develop ...
Manufactured by:Synbio Technologies LLC based in, NEW JERSEY (USA)
In recent years, the proportion of biological drugs in the global pharmaceutical market has been close to 20%. The focus within the global pharmaceutical market has been gradually shifting from small molecule chemical drugs to biomacromolecules (biological drugs). It also appears that the trend is gradually expanding. Biological drugs are a broad class of pharmaceuticals generated by using ...